Hypertension and microalbuminuria: the new detrimental duo. (Q35974034)

11 August 2017

1 reference

title

Hypertension and microalbuminuria: the new detrimental duo. (English)

1 reference

11 August 2017

2

Gian Paolo Reboldi

1 reference

11 August 2017

Paolo Verdecchia

1

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

198-211

1 reference

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Clinical value of microalbuminuria in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Urinary albumin measurement by immunoturbidimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Increased urinary albumin-excretion rate in benign essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Albuminuria in normals and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Combined renal effects of overweight and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Dual effect of insulin on plasma volume and transcapillary albumin transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria is an early marker of target organ damage in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Renal disease and hypertension in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Renal Factors Influencing Blood Pressure Threshold and Choice of Treatment for Hypertension in IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Management of dyslipidemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vasc

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050410016456

10.1080/08037050410016456

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference